Hims & Hers Health: Q3 Revenue Increases 49% To $890.4 Million

Hims & Hers Health reported third-quarter 2026 revenue of $890.4 million, up 49% from $599 million a year earlier, as its international business expanded rapidly and its subscriber base approached 2.8 million. The health and wellness platform tightened its full-year revenue guidance while reducing its adjusted EBITDA outlook.

U.S. revenue increased 21% to $657.1 million, while revenue outside the U.S. rose 321% to $233.3 million. Total subscribers reached 2.788 million at the end of the quarter, an increase of 13% from 2.471 million in the prior-year period. Monthly revenue per average subscriber increased 30% to $105.

Growth was accompanied by lower reported profitability and cash generation. Gross margin declined to 57% from 74% a year earlier. Hims & Hers recorded a net loss of $33 million, compared with net income of $15.8 million in the third quarter of 2025. Adjusted EBITDA increased to $82.4 million from $78.4 million.

Net cash provided by operating activities was $65.4 million, down from $148.7 million in the prior-year quarter. Free cash flow totaled $26 million, compared with $79.4 million a year earlier. Management said it deliberately paced marketing spending ahead of planned platform expansions, supported by its balance sheet and continuing cash generation.

For the fourth quarter, Hims & Hers projected revenue of $875 million to $895 million and adjusted EBITDA of $70 million to $90 million, representing an adjusted EBITDA margin of 8% to 10%. The company expects the planned expansions to position the business for continued growth heading into 2027.

Full-year 2026 revenue guidance was tightened to a range of $3.13 billion to $3.15 billion. The adjusted EBITDA forecast was reduced to $257 million to $277 million, implying a margin of 8% to 9%. The results highlight the scale of the company’s customer platform and international opportunity while also showing the near-term cost of investing in new specialties, treatments, and technology.

KEY QUOTES:

“In healthcare, whoever owns the customer relationship wins, and that’s exactly what we’re building toward at Hims & Hers. Today, customers want real choice, real value, and a care team that knows them. Everything we’re doing, from expanding the treatments and specialties we make available, to rolling out an AI-native experience to support every customer’s care, informed by leading minds in health and science, is designed to meet that higher bar. The platform people can rely on for their health every day, in every category, and every market, is the platform that will transform the industry. We believe we are building that platform.”

Andrew Dudum, Co-Founder and Chief Executive Officer of Hims & Hers Health

“In the third quarter, we continued to apply what we’ve learned to make deliberate strategic decisions to position Hims & Hers for durable, multi-year growth. Revenue grew 49% year-over-year, our second consecutive quarter of acceleration, with domestic revenue up 21% year-over-year and international revenue up more than 300% year-over-year. We delivered those results while intentionally pacing marketing spend ahead of several planned expansions to our platform in the fourth quarter, which we expect will set us up well heading into 2027. Our strong balance sheet and durable cash flow generation give us the flexibility to invest with conviction behind our long-term objective of becoming the first place people turn for their daily health needs, globally.”

Yemi Okupe, Chief Financial Officer of Hims & Hers Health